Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients

Area of Science:

• Neuro-oncology
• Radiation Oncology
• Clinical Oncology

Background:

• Glioblastoma is the most common primary malignant brain tumor, characterized by a poor prognosis despite advances in treatment.
• Current median survival is approximately 1 year, with less than 5% 5-year survival rates.
• Age and performance status are key prognostic factors, and postoperative radiation therapy improves outcomes.

Purpose of the Study:

• To evaluate the current knowledge on alternative radiotherapy schedules for elderly and poor-prognosis glioblastoma patients.
• To assess the feasibility and efficacy of modified radiation schedules in this patient cohort.
• To review evidence regarding the necessity of the standard 60 Gy/6-week schedule for older patients.

Main Methods:

• Systematic review of existing literature on glioblastoma treatment.
• Analysis of studies investigating alternative radiotherapy fractionation and schedules.
• Evaluation of patient outcomes, including survival and functional capacity, in relation to treatment regimens.

Main Results:

• Postoperative radiation therapy demonstrates survival benefits, even in patients aged 70 years and over.
• Concerns exist regarding the necessity of the standard 60 Gy/6-week schedule for elderly patients with limited performance status.
• Alternative schedules are being explored to mitigate treatment inconvenience and morbidity.

Conclusions:

• Alternative radiotherapy schedules warrant further investigation for elderly and poor-prognosis glioblastoma patients.
• Tailoring treatment schedules may improve patient tolerance and adherence while maintaining efficacy.
• Further research is needed to establish optimal alternative fractionation schemes for specific patient subgroups.